Astellas Pharma Inc. (TYO:4503)
2,347.50
-14.00 (-0.59%)
At close: Mar 16, 2026
Astellas Pharma Employees
Astellas Pharma had 13,643 employees as of March 31, 2025. The number of employees decreased by 1,111 or -7.53% compared to the previous year.
Employees
13,643
Change (1Y)
-1,111
Growth (1Y)
-7.53%
Revenue / Employee
151.04M JPY
Profits / Employee
23.67M JPY
Market Cap
4.23T
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 13,643 | -1,111 | -7.53% |
| Mar 31, 2024 | 14,754 | 270 | 1.86% |
| Mar 31, 2023 | 14,484 | -38 | -0.26% |
| Mar 31, 2022 | 14,522 | -933 | -6.04% |
| Mar 31, 2021 | 15,455 | -428 | -2.69% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Otsuka Holdings | 37,758 |
| Daiichi Sankyo Company | 19,765 |
| Chugai Pharmaceutical | 7,872 |
| Kyowa Kirin | 5,669 |
| Ono Pharmaceutical | 4,287 |
| Santen Pharmaceutical | 3,849 |
| JCR Pharmaceuticals | 987 |
| Perseus Proteomics | 32 |
Astellas Pharma News
- 19 days ago - These Analysts Boost Their Forecasts On Vir Biotechnology - Benzinga
- 20 days ago - Vir Biotechnology Stock Hits 52-Week High Tuesday - Here's Why - Benzinga
- 20 days ago - What's Happening With VIR Stock? - Forbes
- 20 days ago - Vir Biotech Soars On Global Collaboration With Astellas, Encouraging Prostate Cancer Drug Data - Nasdaq
- 20 days ago - Vir Biotech Catapults 65% On A $1.71 Billion Deal With Astellas - Investor's Business Daily
- 20 days ago - Astellas collaborates with Vir to develop its experimental prostate cancer drug - Reuters
- 20 days ago - Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer - PRNewsWire
- 4 weeks ago - India's Lupin clears patent hurdle with Astellas Pharma, keeps Mirabegron sales in US - Reuters